Free Trial

UiPath (NYSE:PATH) Upgraded at UBS Group

UiPath logo with Computer and Technology background

Key Points

  • UiPath received a "hold" rating upgrade from UBS Group, while other analysts have mixed views, with Zacks Research upgrading it to "strong-buy" and Weiss Ratings maintaining a "sell" rating.
  • UiPath's share price increased by 6.6% recently, opening at $16.45, with a target price consensus of $13.71.
  • Insider activity shows significant stock sales by CFO Ashim Gupta and CEO Daniel Dines, indicating a decrease in their holdings by 25.71% and 16.67%, respectively.
  • MarketBeat previews top five stocks to own in November.

UiPath (NYSE:PATH - Get Free Report) was upgraded by analysts at UBS Group to a "hold" rating in a research report issued on Thursday, MarketBeat Ratings reports.

Other analysts have also issued reports about the company. Zacks Research raised UiPath from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 8th. Cowen reaffirmed a "hold" rating on shares of UiPath in a research note on Friday, September 5th. Wall Street Zen lowered UiPath from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Weiss Ratings reaffirmed a "sell (d)" rating on shares of UiPath in a research note on Wednesday, October 8th. Finally, BMO Capital Markets lifted their price objective on UiPath from $12.50 to $13.00 and gave the company a "market perform" rating in a research note on Thursday, October 2nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, UiPath currently has an average rating of "Hold" and a consensus target price of $13.71.

Check Out Our Latest Research Report on UiPath

UiPath Trading Up 6.6%

Shares of NYSE:PATH opened at $16.45 on Thursday. The stock's 50-day moving average price is $13.03 and its two-hundred day moving average price is $12.41. UiPath has a 12-month low of $9.38 and a 12-month high of $18.74. The firm has a market cap of $8.74 billion, a price-to-earnings ratio of 548.43, a PEG ratio of 5.71 and a beta of 1.07.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The firm had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. During the same period last year, the company earned $0.04 EPS. The firm's quarterly revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, research analysts forecast that UiPath will post -0.17 earnings per share for the current fiscal year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 240,874 shares of the business's stock in a transaction that occurred on Thursday, October 9th. The stock was sold at an average price of $17.28, for a total transaction of $4,162,302.72. Following the transaction, the chief financial officer directly owned 696,117 shares of the company's stock, valued at approximately $12,028,901.76. The trade was a 25.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Daniel Dines sold 122,734 shares of the business's stock in a transaction that occurred on Wednesday, October 8th. The stock was sold at an average price of $14.89, for a total value of $1,827,509.26. Following the transaction, the chief executive officer directly owned 613,670 shares in the company, valued at $9,137,546.30. This trade represents a 16.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,193,990 shares of company stock worth $31,702,831 over the last three months. 23.19% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On UiPath

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in UiPath by 3.0% during the 1st quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company's stock worth $495,029,000 after purchasing an additional 1,396,972 shares during the last quarter. TFG Asset Management GP Ltd increased its holdings in UiPath by 53.3% during the 2nd quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company's stock worth $175,645,000 after purchasing an additional 4,772,244 shares during the last quarter. AQR Capital Management LLC increased its holdings in UiPath by 76.0% during the 2nd quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company's stock worth $145,732,000 after purchasing an additional 4,926,341 shares during the last quarter. Federated Hermes Inc. increased its holdings in UiPath by 40.7% during the 2nd quarter. Federated Hermes Inc. now owns 8,048,321 shares of the company's stock worth $103,019,000 after purchasing an additional 2,328,225 shares during the last quarter. Finally, State Street Corp increased its holdings in UiPath by 5.0% during the 2nd quarter. State Street Corp now owns 8,032,345 shares of the company's stock worth $102,814,000 after purchasing an additional 378,851 shares during the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Analyst Recommendations for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

500 Stocks Have Already Doubled — Here’s the Next One
The Next Big Stock Winner Behind Massive AI Incentives
5 Ways AI Is Creating Massive Profits — and the Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines